Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00152555
What this trial is testing

Physical Therapy for Systemic Lupus Erythematosus (SLE)

Who this might be right for
Lupus Erythematosus, SystemicSLE
University of Chicago 100
Testing effectiveness (Phase 2)Study completedNCT06717815
What this trial is testing

Phase IIa Study for IPG11406 in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Nanjing Immunophage Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Looking for participantsNCT06660355
What this trial is testing

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

Who this might be right for
Chronic Graft-versus-host Disease (cGVHD)
H. Lee Moffitt Cancer Center and Research Institute 120
Testing effectiveness (Phase 2)Study completedNCT03951259
What this trial is testing

Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
RenJi Hospital 32
Large-scale testing (Phase 3)Study completedNCT00025818
What this trial is testing

Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

Who this might be right for
Keratoconjunctivitis SiccaSjogren's SyndromeLupus Erythematosus, Systemic+2 more
Allergan 290
Post-approval studies (Phase 4)Study completedNCT04146220
What this trial is testing

Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 32
Post-approval studies (Phase 4)Study completedNCT00815282
What this trial is testing

Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease

Who this might be right for
Juvenile Idiopathic ArthritisSystemic Lupus ErythematosusJuvenile Dermatomyositis
N.M. Wulffraat 135
Not applicableLooking for participantsNCT07258524
What this trial is testing

PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis

Who this might be right for
ANCA Associated Vasculitis (AAV)
University of Edinburgh 120
Testing effectiveness (Phase 2)Study completedNCT00506896
What this trial is testing

Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Federal University of São Paulo 60
Not applicableStudy completedNCT00001760
What this trial is testing

Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals

Who this might be right for
Atopic DermatitisHealthyMastocytosis
National Institute of Allergy and Infectious Diseases (NIAID) 40
Very early researchLooking for participantsNCT07629596
What this trial is testing

Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)

Who this might be right for
Systemic Lupus ErythematosusAutoimmune Hemolytic Anemia (AIHA)
Circunited BioPharma (Shenzhen) Co., Ltd. 5
Large-scale testing (Phase 3)Ended earlyNCT02041091
What this trial is testing

Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Who this might be right for
Lupus Erythematosus, Systemic
Eli Lilly and Company 226
Not applicableUnknownNCT01729624
What this trial is testing

PRO Development for ANCA Associated Vasculitis

Who this might be right for
Wegener GranulomatosisMicroscopic PolyangiitisChurg-Strauss Syndrome
University of Oxford 50
Not applicableUnknownNCT05351060
What this trial is testing

Novel Splinting Technique Using 3D Models

Who this might be right for
ArthritisOsteoarthritis HandScleroderma, Systemic+2 more
Giovanna Fichera 10
Testing effectiveness (Phase 2)Looking for participantsNCT07363460
What this trial is testing

Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN

Who this might be right for
Lupus Nephritis (LN)
Haisco Pharmaceutical Group Co., Ltd. 105
Not applicableStudy completedNCT04345159
What this trial is testing

Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease

Who this might be right for
SARS-CoV-2Systemic Lupus ErythematosusRheumatoid Arthritis+2 more
Fondation Ophtalmologique Adolphe de Rothschild 572
Early research (Phase 1)Study completedNCT00960362
What this trial is testing

An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)

Who this might be right for
InflammationSystemic Lupus Erythematosus (SLE)
Argos Therapeutics 13
Not applicableStudy completedNCT00042523
What this trial is testing

Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT06559163
What this trial is testing

Obexelimab in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Zenas BioPharma (USA), LLC 190
Not applicableLooking for participantsNCT05098821
What this trial is testing

Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation

Who this might be right for
Atopic Dermatitis
Charite University, Berlin, Germany 25
Next Page